Research

In vitro antifungal activity of hydroxychavicol isolated from Piper betle L

Intzar Ali¹ , Farrah G Khan³ , Krishan A Suri² , Bishan D Gupta² , Naresh K Satti² , Prabhu Dutt² , Farhat Afrin⁴ , Ghulam N Qazi⁴ and Inshad A Khan¹

¹  Clinical Microbiology Division Indian Institute of Integrative Medicine, Canal Road, Jammu-180 001, India

²  Natural Product Chemistry Division, Indian Institute of Integrative Medicine, Canal Road, Jammu-180 001, India

³  Department of Microbiology, Acharya Shri Chander College of Medical Sciences, Sidhra, Jammu-180 017, India

⁴  Department of Biotechnology, Faculty of Science, Hamdard University, Hamdard Nagar, New Delhi-110 062, India

author email corresponding author email

Annals of Clinical Microbiology and Antimicrobials 2010, 9:7doi:10.1186/1476-0711-9-7

Published:	3 February 2010

Abstract

Background

Hydroxychavicol, isolated from the chloroform extraction of the aqueous leaf extract of Piper betle L., (Piperaceae) was investigated for its antifungal activity against 124 strains of selected fungi. The leaves of this plant have been long in use tropical countries for the preparation of traditional herbal remedies.

Methods

The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of hydroxychavicol were determined by using broth microdilution method following CLSI guidelines. Time kill curve studies, post-antifungal effects and mutation prevention concentrations were determined against Candida species and Aspergillus species "respectively". Hydroxychavicol was also tested for its potential to inhibit and reduce the formation of Candida albicans biofilms. The membrane permeability was measured by the uptake of propidium iodide.

Results

Hydroxychavicol exhibited inhibitory effect on fungal species of clinical significance, with the MICs ranging from 15.62 to 500 μg/ml for yeasts, 125 to 500 μg/ml for Aspergillus species, and 7.81 to 62.5 μg/ml for dermatophytes where as the MFCs were found to be similar or two fold greater than the MICs. There was concentration-dependent killing of Candida albicans and Candida glabrata up to 8 × MIC. Hydroxychavicol also exhibited an extended post antifungal effect of 6.25 to 8.70 h at 4 × MIC for Candida species and suppressed the emergence of mutants of the fungal species tested at 2 × to 8 × MIC concentration. Furthermore, it also inhibited the growth of biofilm generated by C. albicans and reduced the preformed biofilms. There was increased uptake of propidium iodide by C. albicans cells when exposed to hydroxychavicol thus indicating that the membrane disruption could be the probable mode of action of hydroxychavicol.

Conclusions

The antifungal activity exhibited by this compound warrants its use as an antifungal agent particularly for treating topical infections, as well as gargle mouthwash against oral Candida infections.